In December 2024, Lilly announced another $3 billion to expand an existing plant in Kenosha County, Wisconsin ( [8] )
As demand surged in recent years, many compounders, outsourcing facilities, telehealth providers, and drug marketers entered the market with compounded versions of semaglutide, tirzepatide, and other GLP-1 products
Loss of the Parkinsons disease-linked gene DJ-1 perturbs mitochondrial dynamics
Current therapeutic options span both pharmacological and behavioral realms
Patients and prescribers should consult the most current SmPC once available, alongside relevant NICE guidance, before initiating retatrutide alongside any existing medication regimen